AMENDED AND RESTATED MUTUAL CONFIDENTIALITY AGREEMENTMutual Confidentiality Agreement • December 22nd, 2020 • ELI LILLY & Co • Pharmaceutical preparations • Delaware
THIS AMENDED AND RESTATED MUTUAL CONFIDENTIALITY AGREEMENT (the “Agreement”) is entered into on the last date signed below, between Eli Lilly and Company, having its principal place of business at Lilly Corporate Center, Indianapolis, Indiana 46285, U.S.A. (“Lilly”), and Prevail Therapeutics Inc., having its principal place of business at 430 East 29th Street, Suite 940, New York, New York 10016, USA (“Prevail”) (collectively, “Parties” or in the singular “Party”).
